2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxyl-methyl)phenyl isobutyrate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxyl-methyl)phenyl isobutyrate
• 英文别名: Fesoterodine；FESO；isobutyric acid 2-(3-N,N-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenyl ester；isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester；2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl isobutyrate；2-(3-N,N-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenyl ester；[2-[3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate
• 化学式: C₂₆H₃₇NO₃
• 分子量: 411.585
• InChiKey: DCCSDBARQIPTGU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  30
• 可旋转键数：
  11
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  49.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxyl-methyl)phenyl isobutyrate 以 甲醇 、 水 为溶剂， 反应 1.0h， 生成 5-羟甲基托特罗定 、 、 、 2-(3-(diisopropylamino)propyl)-4-(hydroxymethyl)phenol 、 2-(3-(diisopropylamino)-1-phenylpropyl)phenol 、 4-(hydroxymethyl)-2-(3-(isopropylamino)-1-phenylpropyl)phenyl isobutyrate 、 4-(hydroxymethyl)-2-(3-(isopropylamino)propyl)phenyl isobutyrate
  参考文献：
  名称：

  Photochemistry of a novel antimuscarinic drug fesoterodine and identification of its photodegradation products by LC–ESI–MS studies

  摘要：

  Fesoterodine (FESO) is a novel muscarinic receptor antagonist for the treatment of overactive bladder syndrome. The aim of this work was to study the photodegradation of FESO, to determine its kinetics and to identify the photodegradation products. The photochemistry of FESO was investigated in sample solutions exposed to a UV-A (320-400 nm) and UV-C irradiation (100-280 nm) at room temperature. The photodegradation process was monitored by means of liquid chromatography method equipped with monolithic column and photodiode array detector. This drug is more photolabile under UV-C light. In methanol-water solution (1:1, v/v), approximately 62.5% of FESO decomposes after 60 min of UV-C irradiation, whereas under 6 h of UV-A light only 4.9% decomposes. FESO was shown to be photolabile and its photodegradation reaction followed the zero-order kinetics with the rate constant k = 0.5503 min(-1), and t(1/2) and t(90%) obtained were 46.92 min and 9.38 min, respectively. The main degradation products were isolated by semi-preparative liquid chromatography and identified by liquid chromatography coupled to an electrospray ionization mass spectrometry. The powdered and intact tablets were also exposed to UV-C irradiation. Based on the obtained results, a complete drug photodegradation pathway was proposed. (C) 2013 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.jphotochem.2013.02.003
• 作为产物：
  描述：

  肉桂基氯 在 硼烷四氢呋喃络合物 、 硫酸 、 溶剂黄146 、 三乙胺 、 sodium iodide 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 为溶剂， 生成 2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxyl-methyl)phenyl isobutyrate
  参考文献：
  名称：

  Process for obtaining 3,3-diphenylpropylamines

  摘要：

  公开号：

  EP2281801B1

文献信息

• PROCESS FOR PREPARATION OF PHENOLIC MONOESTERS OF HYDROXYMETHYL PHENOLS
  申请人：DESAI Sanjay Jagdish

  公开号：US20110282094A1

  公开（公告）日：2011-11-17

  A process for the preparation of phenolic monoesters of 2-(3-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol by converting (±)6-halo-4-phenylchroman-2-one to (±)4-halo-2-(3-hydroxy-1-phenylpropyl)phenol. The two hydroxyl groups are protected and the protected compound is reacted with diisopropylamine to give (±)[3-(2-benzyloxy-5-halophenyl)-3-phenylpropyl]diisopropylamine. The halo substituent on the benzene ring is converted to corresponding benzyl alcohol and then the protection is removed to give racemic 5-HMT. Racemic 5-HMT is converted R enantiomer and then it is esterified.

  一种制备2-(3-二异丙基氨基-1-苯基丙基)-4-(羟甲基)酚的酚单酯的方法，通过将(±)6-卤代-4-苯基色苷-2-酮转化为(±)4-卤代-2-(3-羟基-1-苯基丙基)酚。两个羟基团被保护，保护化合物与二异丙基胺反应，得到(±)[3-(2-苄氧基-5-卤苯基)-3-苯基丙基]二异丙基胺。苯环上的卤代取代基被转化为相应的苄醇，然后去除保护作用，得到外消旋的5-HMT。外消旋的5-HMT转化为R对映体，然后酯化。
• PROCESS FOR THE PREPARATION OF FESOTERODINE WITH LOW IMPURITIES CONTENT
  申请人：ARTICO Marco

  公开号：US20110152367A1

  公开（公告）日：2011-06-23

  Disclosed is a process for the preparation of (R)-2-(3-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)-phenol isobutyrate (Fesoterodine) or a pharmaceutically acceptable salt thereof having a low content of impurities such as tolterodine and tolterodine isobutyrate.

  揭示了一种用于制备(R)-2-(3-二异丙胺基-1-苯基丙基)-4-(羟甲基)-苯酚异丁酸酯（费索特罗定）或其低杂质含量的药用盐的方法，如托特罗定和托特罗定异丁酸酯。
• Process for the preparation of fesoterodine
  申请人：Dipharma Francis S.r.l.

  公开号：EP2316817A1

  公开（公告）日：2011-05-04

  A process for the preparation of (R)-2-(3-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)-phenol isobutyrate (Fesoterodine), its (S)-enantiomer, and novel intermediates useful in thei synthesis.

  一种用于制备(R)-2-(3-二异丙基氨基-1-苯基丙基)-4-(羟甲基)-苯酚异丁酸酯（费索特罗定，Fesoterodine）及其(S)-对映体的方法，以及在它们的合成中有用的新型中间体。
• PROCESS FOR THE PREPARATION OF FESOTERODINE
  申请人：Mantegazza Simone

  公开号：US20110105783A1

  公开（公告）日：2011-05-05

  A process for the preparation of (R)-2-(3-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)-phenol isobutyrate (Fesoterodine), its (S)-enantiomer, and novel intermediates useful in thei synthesis.

  一种用于制备(R)-2-(3-二异丙基氨基-1-苯基丙基)-4-(羟甲基)-苯酚异丁酸酯（费索特罗定，Fesoterodine），其（S）-对映体以及在它们合成中有用的新型中间体的方法。
• [EN] SHORT SYNTHESIS OF TOLTERODINE, INTERMEDIATES AND METABOLITES<br/>[FR] SYNTHÈSE COURTE DE TOLTÉROPINE, INTERMÉDIAIRES ET MÉTABOLITES
  申请人：LEK PHARMACEUTICALS

  公开号：WO2011110556A1

  公开（公告）日：2011-09-15

  A process is described for the preparation of intermediates which can be used for preparation of agents for urinary incontinence therapy, specifically to 2-(3-(diisopropylamino)- 1-phenylpropyl)-4-(hydroxymethyl)phenol and its prodrugs.

  描述了一种用于制备中间体的过程，这些中间体可用于制备尿失禁治疗药物，特别是用于2-(3-(二异丙基氨基)-1-苯基丙基)-4-(羟甲基)苯酚及其前药的制备。